Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must have completed (neo) adjuvant endocrine therapy and have cancer return after at least 12 months or have de novo cancer that has spread to other organs at diagnosis
Participants must have 1 or more of the following:
* A high grade tumor in tissue
* Negative progesterone receptor (PR) status
* Have cancer that has spread to the liver
* Have a treatment-free interval (TFI) \<36 months
Participants must have HR+, HER2- breast cancer
Participants must have adequate organ function
You may not be if
Participants must not have cancer that has spread to other organs that has severely affected their function
Participants must not have cancer that has spread to the brain that is unstable or untreated
Participants must not have received endocrine therapy in the metastatic setting
Participants must not have known active infection
Participants must not have received prior endocrine therapy and had disease return within 12 months from completion of treatment
Participants must not have received prior treatment with any cyclin-dependent kinase (CDK) 4 \& 6 inhibitor or everolimus
